Midd Immunogenicity Workshop

Media Summary: Lora Hamuro, PhD. - Quantitative Assessment of the Peter Marks, MD. PhD. – Welcome Remarks. Rajanikanth Madabushi, PhD. – Integration of

Midd Immunogenicity Workshop - Detailed Analysis & Overview

Lora Hamuro, PhD. - Quantitative Assessment of the Peter Marks, MD. PhD. – Welcome Remarks. Rajanikanth Madabushi, PhD. – Integration of Peter Gilbert, PhD. - Learning Immune Correlates of Protection from Vaccine Efficacy Trials. Morten Nielsen, PhD. - The use of HLA class II antigen presentation prediction in the context of Brandon Dekosky, PhD. - Exploring Personalization of Human Immune Responses with High-Throughput Immune Receptor Data.

I created this talk to explain the fundamentals of the accurate CLINICAL INTERPRETATION of Malachi Griffith, PhD. - Bioinformatics and immunogenomics approaches for neoantigen target identification. Richard White, PhD. and Sophie Rhodes, Ph.D - Using Epidemiological and Immunostimulation/Immunodynamic modelling to ... Nirjal Bhattarai, PhD. - mmunogenicity of Chimeric Antigen Receptor T Cells.

Photo Gallery

MIDD Immunogenicity Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

General principles Clinical interpretation of immunogenicity

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

View Detailed Profile

MIDD Immunogenicity Workshop

MIDD Immunogenicity Workshop

Do you have questions for the

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Lora Hamuro, PhD. - Quantitative Assessment of the

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Peter Marks, MD. PhD. – Welcome Remarks.

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Jochem Gokemeijer, PhD. - Pre-clinical

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Guangping Gao, PhD. - Vector-related

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Rajanikanth Madabushi, PhD. – Integration of

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Peter Gilbert, PhD. - Learning Immune Correlates of Protection from Vaccine Efficacy Trials.

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Morten Nielsen, PhD. - The use of HLA class II antigen presentation prediction in the context of

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Brandon Dekosky, PhD. - Exploring Personalization of Human Immune Responses with High-Throughput Immune Receptor Data.

General principles Clinical interpretation of immunogenicity

General principles Clinical interpretation of immunogenicity

I created this talk to explain the fundamentals of the accurate CLINICAL INTERPRETATION of

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Malachi Griffith, PhD. - Bioinformatics and immunogenomics approaches for neoantigen target identification.

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Richard White, PhD. and Sophie Rhodes, Ph.D - Using Epidemiological and Immunostimulation/Immunodynamic modelling to ...

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Nirjal Bhattarai, PhD. - mmunogenicity of Chimeric Antigen Receptor T Cells.